Premature aging syndrome

Advances in Experimental Medicine and Biology

Volumn 724, Issue , 2012, Pages 317-331

  Coppedè, Fabio ^a  

^a UNIVERSITY OF PISA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

LAMIN A; WERNER SYNDROME PROTEIN;

ARTICLE; CLINICAL FEATURE; DNA REPLICATION; GENE; GENE EXPRESSION REGULATION; GENETIC EPIDEMIOLOGY; HUMAN; LAMIN A GENE; MISSENSE MUTATION; MOLECULAR DIAGNOSIS; MOLECULAR MODEL; MOLECULAR PATHOLOGY; MUTATIONAL ANALYSIS; NEUROPATHOLOGY; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROGERIA; TRANSCRIPTION REGULATION; WERNER SYNDROME; WRN GENE; GENETICS; METABOLISM; PREMATURE AGING; REVIEW;

AGING, PREMATURE; HUMANS; PROGERIA; WERNER SYNDROME;

EID: 84859527977     PISSN: 00652598     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-4614-0653-2_24     Document Type: Article

References (78)

1. Navarro CL, CauP, Levy N. Molecular bases ofprogeroid syndromes. Hum Mol Genet 2006; 15:R151-161.
2. Kudlow BA, Kennedy BK, Monnat RJ Jr. Werner and Hutchinson-Gilford progeria syndromes: mechanistic basis ofhuman progeroid diseases. Nat Rev Mol Cell Biol 2007; 8:394-404.
3. Ding SL, Shen CY. Model ofhuman aging: recent findings on Werner's and Hutchinson-Gilford progeria syndromes. Clin Interv Aging 2008; 3:431-444.
4. Dominguez-Gerpe L, Araujo-Vilar D. Prematurely aged children: molecular alterations leading to Hutchinson-Gilford progeria and Werner syndromes. Curr Aging Sci 2008; 1:202-212.
5. Pollex RL, Hegele RA. Hutchinson-Gilford progeria syndrome. Clin Genet 2004; 66:375-381.
6. Satoh M, Imai M, Sugimoto M et al. Prevalence of Werner's syndrome heterozygotes in Japan. Lancet 1999; 353:1766.
7. Goto M. Clinical aspects of Werner's syndrome: Its natural history and the genetics of the disease. In: Lebel M, ed. Molecular Mechanisms of Werner's Syndrome. New York: Kluver Academic Plenum Publishers, 2004:1-11.
8. MasalaMV, Scapaticci S, Olivieri C et al. Epidemiology and clinical aspects of Werner's syndrome in North Sardinia: description of a cluster. Eur J Dermatol 2007; 17:213-216.
9. Hutchinson J. Congenital absence of hair and mammary glands with atrophic condition of the skin and its appendages. Trans Med Chir Soc Edinburgh 1886; 69:473-477.
10. Gilford H. On a condition ofmixedpremature and immature development. Med Chirurg Trans 1987;80:17-45.
11. Gilford H. Progeria: A form of senilism. Practitioner 1904; 73:188-217.
12. Gordon LB, McCarten KM, Giobbie-Hurder A et al. Disease progression in Hutchinson-Gilford progeria syndrome: impact on growth and development. Pediatrics 2007; 120:824-833.
13. Brown WT, Gordon LB, Collins FS. Hutchinson-Gilford Progeria syndrome. In: Pagon RA, Bird TC, Dolan CR et al, eds. GeneReviews [Internet]. Seattle: University of Washington, Seattle; 1993-2003 [updated 2006].
14. Hennekam RC. Hutchinson-Gilford progeria syndrome: review of the phenotype. Am J Med Genet A 2006; 140:2603-2624.
15. Pereira S, Bourgeois P, Navarro C et al. HGPS and related premature aging disorders: from genomic identification to the first therapeutic approaches. Mech Ageing Dev 2008; 129:449-459.
16. Muftuoglu M, Oshima J, von Kobbe C et al. The clinical characteristics of Werner syndrome: molecular and biochemical diagnosis. Hum Genet 2008; 124:369-377.
17. GotoM. Hierarchical deterioration of body systems in Werner's syndrome: implications for normal ageing. Mech Ageing Dev 1997; 98:239-254.
18. Epstein CJ, Martin GM, Schultz AL et al. Werner's syndrome a review of its symptomatology, natural history, pathologic features, genetics and relationship to the natural aging process. Medicine (Baltimore) 1966; 45:177-221.
19. Huang S, Lee L, Hanson NB et al. The spectrum of WRN mutations in Werner syndrome patients. Hum Mutat 2006; 27:558-567.
20. Ishikawa Y, Sugano H, Matsumoto T et al. Unusual features of thyroid carcinomas in Japanese patients with Werner syndrome and possible genotype-phenotype relations to cell type and race. Cancer 1999; 85:1345-1352.
21. Leistritz DF, Hanson N, Martin GM et al. Werner Syndrome. In: Pagon RA, Bird TC, Dolan CR et al, eds. GeneReviews [Internet]. Seattle: UniversityofWashington, 1993-2002 [updated2007].
22. Eriksson M, Brown WT, Gordon LB etal. Recurrent de novo point mutations in lamin A cause Hutchinson-Gilfordprogeria syndrome. Nature 2003; 423:293-298.
23. De Sandre-Giovannoli A, Bernard R, Cau P et al. Lamin a truncation in Hutchinson-Gilford progeria. Science 2003; 300:2055.
24. Machiels BM, Zorenc AH, Endert JM et al. An alternative splicing product of the lamin A/C gene lacks exon 10. J Biol Chem 1996; 271:9249-9253.
25. Rodriguez S, Coppede F, Sagelius H et al. Increased expression of the Hutchinson-Gilford progeria syndrome truncated lamin A transcript during cell aging. Eur J Hum Genet 2009; 17:928-937.
26. Furukawa K, Inagaki H, Hotta Y. Identification and cloning of an mRNA coding for a germ cell-specific A-type lamin in mice. Exp Cell Res 1994; 212:426-430.
27. Beck LA, Hosick TJ, Sinensky M. Isoprenylation is required for the processing of the lamin A precursor. J Cell Biol 1990; 110:1489-1499.
28. Wuyts W, Biervliet M, Reyniers E et al. Somatic and gonadal mosaicism in Hutchinson-Gilford progeria. Am J Med Genet A 2005; 135:66-68.
29. Jacob KN, GargA. Laminopathies: multisystem dystrophy syndromes. Mol Genet Metab 2006; 87:289-302.
30. Fukuchi K, Katsuya T, Sugimoto K et al. LMNA mutation in a 45 year old Japanese subject with Hutchinson-Gilford progeria syndrome. J Med Genet 2004; 41:e67.
31. Shalev SA, De Sandre-Giovannoli A, Shani AA et al. An association of Hutchinson- Gilford progeria and malignancy. Am J Med Genet A 2007; 143A:1821-1826.
32. Navarro CL, De Sandre-Giovannoli A, Bernard R et al. Lamin A and ZMPSTE24 (FACE-1) defects cause nuclear disorganization and identify restrictive dermopathy as a lethal neonatal laminopathy. Hum Mol Genet 2004; 13:2493-503.
33. Navarro CL, Cadinanos J, De Sandre-Giovannoli A et al. Loss of ZMPSTE24 (FACE-1) causes autosomal recessive restrictive dermopathy and accumulation of Lamin A precursors. Hum Mol Genet 2005; 14:1503-1513.
34. Moulson CL, Fong LG, Gardner JM et al. Increased progerin expression associated with unusual LMNA mutations causes severe progeroid syndromes. Hum Mutat 2007; 28:882-889.
35. Denecke J, Brune T, Feldhaus T et al. A homozygous ZMPSTE24 null mutation in combination with a heterozygous mutation in the LMNA gene causes Hutchinson-Gilford progeriasyndrome(HGPS): insights into the pathophysiology of HGPS. Hum Mutat 2006; 27:524-531.
36. Plasilova M, Chattopadhyay C, Pal P et al. Homozygous missense mutation in the lamin A/C gene causes autosomal recessive Hutchinson-Gilford progeria syndrome. J Med Genet 2004; 41:609-614.
37. Liang L, Zhang H, Gu X. Homozygous LMNA mutation R527C in atypical Hutchinson-Gilford progeria syndrome: evidence for autosomal recessive inheritance. Acta Paediatr 2009; 98:1365-1368.
38. Verstraeten VL, Broers JL, van Steensel MA et al. Compound heterozygosity for mutations in LMNA causes a progeria syndrome without prelamin A accumulation. Hum Mol Genet 2006; 15:2509-2522.
39. Garg A, Subramanyam L, Agarwal AK et al. Atypical progeroid syndrome due to heterozygous missense LMNA mutations. J Clin Endocrinol Metab 2009; 94:4971-4983.
40. Huang S, Lee L, Hanson NB et al. The spectrum of WRN mutations in Werner syndrome patients. Hum Mutat 2006; 27:558-567.
41. Chen L, Lee L, Kudlow BA et al. LMNA mutations in atypical Werner's syndrome. Lancet 2003; 362:440-445.
42. Dechat T, Pfleghaar K, Sengupta K et al. Nuclear lamins: major factors in the structural organization and function of the nucleus and chromatin. Genes Dev 2008; 22:832-853.
43. Goldman RD, Shumaker DK, Erdos MR et al. Accumulation of mutant lamin A causes progressive changes in nuclear architecture in Hutchinson- Gilford progeria syndrome. Proc Natl Acad Sci USA 2004; 101:8963-8968.
44. Young SG, Meta M, Yang SH et al. Prelamin A farnesylation and progeroid syndromes. J Biol Chem 2006; 281:39741-39745.
45. Scaffidi P, Misteli T. Lamin A-dependent nuclear defects in human aging. Science 2006; 312:1059-1063.
46. Cao K, Capell BC, Erdos MR et al. A lamin A protein isoform overexpressed in Hutchinson-Gilford progeria syndrome interferes with mitosis in progeria and normal cells. Proc Natl Acad Sci USA 2007; 104:4949-4954.
47. McClintock D, Ratner D, Lokuge M et al. The mutant form of lamin A that causes Hutchinson- Gilford progeria is a biomarker of cellular aging in human skin. PLoS ONE 2007; 2:e1269.
48. Liu B, Wang J, Chan KM et al. Genomic instability in laminopathy-based premature aging. Nat Med 2005; 11:780-785.
49. Liu Y, Rusinol A, Sinensky M et al. DNA damage responses in progeroid syndromes arise from defective maturation ofprelamin A. J Cell Sci 2006; 119:4644-4649.
50. Liu Y, Wang Y, Rusinol AE et al. Involvement of xeroderma pigmentosum group A (XPA) in progeria arising from defective maturation of prelamin A. FASEB J 2008; 22:603-611.
51. Musich PR, Zou Y. Genomic instability and DNA damage responses in progeria arising from defective maturation of prelamin A. Aging 2009; 1:28-37.
52. Shumaker DK, Dechat T, Kohlmaier A et al. Mutant nuclear lamin A leads to progressive alterations of epigenetic control in premature aging. Proc Natl Acad Sci USA 2006; 103:8703-8708.
53. Csoka AB, English SB, Simkevich CP et al. Genome-scale expression profiling of Hutchinson-Gilford progeria syndrome reveals widespread transcriptional misregulation leading to mesodermal/mesenchymal defects and accelerated atherosclerosis. Aging Cell 2004; 3:235-243.
54. Decker ML, Chavez E, Vulto I et al. Telomere length in Hutchinson-Gilford progeria syndrome. Mech Ageing Dev 2009; 130:377-383.
55. BrustonF, Delbarre E, OstlundC et al. Loss of a DNA binding site within the tail of prelamin A contributes to altered heterochromatin anchorage by progerin. FEBS Lett 2010; 584:2999-3004.
56. Benson EK, Lee SW, Aaronson SA. Role of progerin-induced telomere dysfunction in HGPS premature cellular senescence. J Cell Sci 2010; [Epub ahead of print].
57. Dechat T, Shimi T, Adam SA et al. Alterations in mitosis and cell cycle progression caused by a mutant lamin A known to accelerate human aging. Proc Natl Acad Sci USA 2007; 104:4955-4960.
58. Scaffidi P, Misteli T. Lamin A-dependent misregulation of adult stem cells associated with accelerated ageing. Nat Cell Biol 2008; 10:452-459.
59. Halaschek-Wiener J, Brooks-Wilson A. Progeria of stem cells: stem cell exhaustion in Hutchinson-Gilford progeria syndrome. J Gerontol A Biol Sci Med Sci 2007; 62:3-8.
60. Dahl KN, Scaffidi P, Islam MF et al. Distinct structural and mechanical properties of the nuclear lamina in Hutchinson-Gilford progeria syndrome. Proc Natl Acad Sci USA 2006; 103:10271-10276.
61. Verstraeten VL, Ji JY, Cummings KS et al. Increased mechanosensitivity and nuclear stiffness in Hutchinson-Gilford progeria cells: effects of farnesyltransferase inhibitors. Aging Cell 2008; 7:383-393.
62. Melcher R, von Golitschek R, Steinlein C et al. Spectral karyotyping of Werner syndrome fibroblast cultures. Cytogenet. Cell Genet 2000; 91:180-185.
63. Yu CE, Oshima J, Wijsman EM et al. Mutations in the consensus helicase domains of the Werner syndrome gene. Werner's Syndrome Collaborative Group. Am J Hum Genet 1997; 60:330-341.
64. Rossi ML, Ghosh AK, Bohr VA. Roles of Werner syndrome protein in protection of genome integrity. DNA Repair 2010; 9:331-344.
65. Coppede F, Migliore L. DNA repair in premature aging disorders and neurodegeneration. Curr Aging Sci 2010; 3:3-19.
66. Haustein J, Pawlas U, Cervos-Navarro J. The Werner syndrome: a case study. Clin Neuropathol 1989;8:147-151.
67. Leverenz JB, Yu CE, Schellenberg GD. Aging-associated neuropathology in Werner syndrome. Acta Neuropathol 1998; 96:421-424.
68. Mori H, Tomiyama T, Maeda N et al. Lack of amyloid plaque formation in the central nervous system of a patient with Werner syndrome. Neuropathology 2003; 23:51-56.
69. Payao SL, de Labio RW, Gatti LL et al. Werner helicase polymorphism is not associated with Alzheimer's disease. J Alzheimers Dis 2004; 6(6):591-4; discussion 673-681.
70. AndersonNE, Haas LF. Neurological complications ofWerner's syndrome. JNeurol2003; 250:1174-1178.
71. Malandrini A, Dotti MT, Villanova M. Neurological involvement in Werner's syndrome: clinical and biopsy study of a familial case. Eur Neurol 2000; 44:187-189.
72. Umehara F, Abe M, Nakagawa M et al. Werner's syndrome associated with spastic paraparesis and peripheral neuropathy. Neurology 1993; 43:1252-1254.
73. Just A, Canaple S, Joly H et al. Neurologic complications in a case of Werner syndrome. Rev Neurol (Paris) 1996; 152:634-636.
74. Kawamura H, Mori S, Murano S et al. Werner's syndrome associated with progressive subcortical vascular encephalopathy of the Binswanger type. Nippon Ronen Igakkai Zasshi 1999; 36:648-651.
75. Varela I, Pereira S, Ugalde AP et al. Combined treatment with statins and aminobisphosphonates extends longevity in a mouse model ofhuman premature aging. Nat Med 2008; 14:767-772.
76. Osorio FG, Obaya AJ, Lopez-Otin C et al. Accelerated ageing: from mechanism to therapy through animal models. Transgenic Res 2009; 18:7-15.
77. Worman HJ, Fong LG, Muchir A et al. Laminopathies and the long strange trip from basic cell biology to therapy. J Clin Invest 2009; 119:1825-1836.
78. Massip L, Garand C, Paquet ER et al. Vitamin C restores healthy aging in a mouse model for Wernersyndrome. FASEB J 2010; 24:158-217.